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A previously healthy, 47-year-old Chinese man presented
with a 3-month history of worsening insomnia, dizziness,
and lethargy. Six months before, he had enrolled into a
weight reduction program using a compound weight-
loss formula. One month before admission, he was diag-
nosed with a sleep disorder and treated by zolpidem 10 mg
per day integrated with aromatherapy, chiropractic mani-
pulation, and bioenergetic therapy. On physical exami-
nation, he was normotensive and the only abnormality
was seen in his fingernails (Figure 1). Laboratory studies
showed hemoglobin 7.2 g/dl, sodium 131 mmol/l, potassium
6.8 mmol/l, blood urea nitrogen 146 mg/dl, creatinine
18.9 mg/dl, and normal liver function. Dipstick urinalysis
revealed mild proteinuria and 12–16 leukocytes per
high-power field, without bacteriuria, hematuria, or cast
formation.
What is the characteristic abnormality seen in his fingernail?
What is the clinical diagnosis?
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Figure 1 | Nail inspection.
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The Diagnosis | Half-and-half nails from end-stage
aristolochic acid nephropathy
Fingernails showed diffuse, dull whitening of the proximal
nail beds, instead of the normal light amber-pink trans-
lucence, and distal pink transverse bands parallel to the free
edge of the nail plates. On constricting venous return from
the nail bed, the distal bands became redder and only
slight pinkness was induced in the proximal area, and the
contrast between the two zones remained sharply demar-
cated. These findings were characteristic of half-and-half
nails, necessitating a comprehensive survey for advanced
renal disease. Histopathological studies and detection of
aristolochic acid in his herbal slimming mixture, using high-
performance liquid chromatography, confirmed diagnosis
of end-stage aristolochic acid nephropathy. However, main-
tenance hemodialysis failed to correct his pseudoleuconychia
completely.
Abnormal fingernails may be pathognomonic of certain
systemic diseases. Across the clinical spectrum of systemic
onychopathies, the half-and-half nail is an occasional, but
specific, manifestation in chronic renal failure.1 Half-and-half
nails (Lindsay’s nails), first described in 1963 by Bean,
typically present as red, pink, or brown transverse distal
bands occupying 20–60% of the total nail length, with
the remaining proximal portion exhibiting a dull whitish
ground-glass appearance. The margin between the distal and
proximal zones, at times irregular, is generally parallel
to the distal or free margin of the nail. In previous studies,
the prevalence of half-and-half nails varied between 15 and
50.6%.2 It is most common in fingernails, but sometimes
can be observed in toenails. There is no known correlation
between the nail band width and the severity or duration
of renal failure, age, sex, proteinuria, or other clinical
parameters. In some reports, it has disappeared after
successful renal transplantation, but is usually unchanged
by dialysis therapy. The mechanism by which half-and-half
nails develop in chronic renal failure remains unclear.3,4
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